Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 622Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Cohance Lifesciences

02 4ALFRED E TIEFENBACHER GmbH & Co KG

03 4G.L. Pharma

04 3Neuraxpharm

05 4Orchid Chemicals & Pharmaceuticals Ltd

06 4Torrent Pharmaceuticals Limited

07 4Unichem Laboratories Limited

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Regulatory Info :

Registration Country : India

Eslicarbazepine

Brand Name :

Dosage Form : Capsule

Dosage Strength : 800MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Cohance

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothCohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Packaging :

Regulatory Info :

Eslicarbazepine

Dosage : Capsule

Dosage Strength : 800MG

Brand Name :

Approval Date :

Application Number :

Registration Country : India

Cohance

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Eslicarbazepine Acetate

Dosage : Tablet

Dosage Strength : 200MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Eslicarbazepine Acetate

Dosage : Tablet

Dosage Strength : 400MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Eslicarbazepine Acetate

Dosage : Tablet

Dosage Strength : 600MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Regulatory Info : Registered in EU

Registration Country : Germany

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 800MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Registered in EU

Registration Country : Germany

Tiefenbacher Compnay Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothWe are the TIEFENBACHER GROUP, Health Pioneers since 1963.

Packaging :

Regulatory Info : Registered in EU

Eslicarbazepine Acetate

Dosage : Tablet

Dosage Strength : 800MG

Brand Name :

Approval Date :

Application Number :

Registration Country : Germany

Tiefenbacher Compnay Banner

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability- Q1 2017

Registration Country : Austria

blank

06

2024 ACI Convention
Not Confirmed
arrow

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability- Q1 2017

Registration Country : Austria

blank

07

2024 ACI Convention
Not Confirmed
arrow

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability- Q1 2017

Registration Country : Austria

blank

08

2024 ACI Convention
Not Confirmed
arrow

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 800MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Dossier Availability- Q1 2017

Registration Country : Austria

blank

09

2024 ACI Convention
Not Confirmed
arrow

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : TABLET

Dosage Strength : 800MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic EU CTD

Registration Country : India

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

14

2024 ACI Convention
Not Confirmed
arrow

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine

Brand Name :

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

15

2024 ACI Convention
Not Confirmed
arrow

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine

Brand Name :

Dosage Form : Tablet

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

blank

16

2024 ACI Convention
Not Confirmed
arrow

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 200MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

17

2024 ACI Convention
Not Confirmed
arrow

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 400MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

18

2024 ACI Convention
Not Confirmed
arrow

19

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 600MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

19

2024 ACI Convention
Not Confirmed
arrow

20

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Eslicarbazepine Acetate

Brand Name :

Dosage Form : Tablet

Dosage Strength : 800MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : India

blank

20

2024 ACI Convention
Not Confirmed
arrow